Results 141 to 150 of about 25,332 (201)
Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report. [PDF]
Clin Case RepBogojevic M +4 more
europepmc +1 more source
DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]
Ann HematolArafat AMA +5 more
europepmc +1 more source
Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution. [PDF]
CureusAhmad CM +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2011
Polycythemia vera is a sporadic myeloproliferative disorder of increased red blood cell mass affecting multiple organ systems. Associated thrombosis, hemorrhaging, and hyperviscosity commonly result in neurological manifestations, sometimes in the form of chorea and ballism.
Michael M, Marvi, Mark F, Lew
openaire +2 more sources
Polycythemia vera is a sporadic myeloproliferative disorder of increased red blood cell mass affecting multiple organ systems. Associated thrombosis, hemorrhaging, and hyperviscosity commonly result in neurological manifestations, sometimes in the form of chorea and ballism.
Michael M, Marvi, Mark F, Lew
openaire +2 more sources
The Indian Journal of Pediatrics, 2008
Polycythemia is defined as a venous hematocrit of over 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion.
M, Jeevasankar +4 more
openaire +2 more sources
Polycythemia is defined as a venous hematocrit of over 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion.
M, Jeevasankar +4 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2003
The differential diagnosis of an elevated hematocrit and the criteria for the diagnosis of polycythemia vera present little or no problem; however, there is not a consensus on therapy. Spivak likened this to a conundrum--"an intricate and difficult problem." Nonetheless, it can be argued that on the basis of the following criteria--life expectancy, the
Nathanial, Berlin, Nathanial I, Berlin
openaire +2 more sources
The differential diagnosis of an elevated hematocrit and the criteria for the diagnosis of polycythemia vera present little or no problem; however, there is not a consensus on therapy. Spivak likened this to a conundrum--"an intricate and difficult problem." Nonetheless, it can be argued that on the basis of the following criteria--life expectancy, the
Nathanial, Berlin, Nathanial I, Berlin
openaire +2 more sources
Polycythemia vera and other primary polycythemias
Current Opinion in Hematology, 2005Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and critically review the published data in context of ...
openaire +2 more sources
The Indian Journal of Pediatrics, 1997
461 consecutive inborn babies, delivered during the period September 1993-March 1994 were subjected to a microhematocrit assessment at 6 hours of age to determine the incidence of polycythemia. 47 babies (inborn and out born), admitted to the neonatal unit with confirmed polycythemia were studied for clinical and laboratory abnormalities.
L, Krishnan, A, Rahim
openaire +2 more sources
461 consecutive inborn babies, delivered during the period September 1993-March 1994 were subjected to a microhematocrit assessment at 6 hours of age to determine the incidence of polycythemia. 47 babies (inborn and out born), admitted to the neonatal unit with confirmed polycythemia were studied for clinical and laboratory abnormalities.
L, Krishnan, A, Rahim
openaire +2 more sources
Hydronephrosis and polycythemia
Urology, 1983Polycythemia is consistently produced in animals undergoing experimental hydronephrosis. This hematologic response is thought to be mediated by a microcirculatory insult and a more accelerated elaboration of erythropoietin by the hydronephrotic kidney.
I, Hirsch, E, Leiter
openaire +2 more sources